Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Eleven Biotherapeutics Inc (NASDAQ:EBIO)

4.72
Delayed Data
As of Aug 26
 +0.04 / +0.85%
Today’s Change
0.25
Today|||52-Week Range
5.97
+56.81%
Year-to-Date
No recent news for Eleven Biotherapeutics Inc.

Today’s Trading

Previous close4.68
Today’s open4.65
Day’s range4.58 - 4.83
Volume521,210
Average volume (3 months)3,621,771
Market cap$94.7M
Dividend yield--
Data as of 4:00pm ET, 08/26/2016

Growth & Valuation

Earnings growth (last year)+25.74%
Earnings growth (this year)+41.41%
Earnings growth (next 5 years)+30.00%
Revenue growth (last year)-55.86%
P/E ratioNM
Price/Sales57.75
Price/Book4.89

Competitors

 Today’s
change
Today’s
% change
SBPHSpring Bank Pharmace...-0.26-2.04%
TBRATobira Therapeutics ...+0.09+1.89%
CTICCTi Biopharma Corp+0.01+1.45%
CPRXCatalyst Pharmaceuti...+0.01+0.93%
Data as of 4:00pm ET, 08/26/2016

Financials

Next reporting date--
EPS forecast (this quarter)--
Annual revenue (last year)$990.0K
Annual profit (last year)-$33.5M
Net profit margin-3,378.99%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Abbie C. Celniker
Chief Financial Officer
John J. McCabe
Corporate headquarters
Cambridge, Massachusetts

Forecasts

Partner Offers

Search for Jobs